(EMAILWIRE.COM, September 15, 2009 ) ImmunoBiotics, Inc. (OTC BB: IMBI) is a nutraceutical company that develops, manufactures, licenses, and sells patented dietary supplements for the treatment and prevention of neurodegenerative, autoimmune, and metabolic diseases including ALS, Autism, Parkinson’s disease, and other neurological diseases. The founders have developed and patented their LutiMax® product, which is an extensively developed, highly researched, and clinically proven formulation of the bioflavonoids Luteolin and Rutin. Luteolin and Rutin are plant pigments found in fruits and vegetables and are proven to have significant benefits, but they are difficult for the body to absorb. The LutiMax® product results in significantly better absorption of Luteolin into the bloodstream. As a result, inflammation is reduced in tissues and organs with restoration of function and tissue repair. LutiMax® is made entirely of naturally occurring substances and are a supplement to the diet. These bioflavonoids have been proven in hundreds of studies published in internationally recognized medical and scientific journals to help treat the symptoms of many autoimmune disorders, inflammatory diseases, allergies, and neurodegenerative diseases.

Contact Information:
Waterville Research
Michael Sweeney
Tel: 212 828 7373
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.